4 Animals AlsterScience GmbH develops innovative therapies for animals. Through targeted use of natural immunomodulators immune function is significantly improved and in sick and old animals optimally restored.
4GENE offers its FLAVOR-ON-DEMAND technology platform of activatable flavor and fragrance glucosides to its Customers in the Cosmetics, Food and Industrial Application Market Segments. 4GENE is a biotech start-up company founded at the Professorship for Biotechnology of Natural Products led by Prof. Dr. Wilfried Schwab at the Technical University Munich. During the EXIST Funding Program 4GENE cooperated with Prof. Dr.-Ing. Ralf Takors, Head of the Institute for Biotechnical Engineering at the University of Stuttgart to provide the Proof-of-Concept for the production of flavor glucosides. Today the company has 8 Employees and operates from Offices in Freising and Stuttgart in Germany with its customers worldwide.
With NUIA 4tiitoo has developed a software suite that will make our interaction with computers more natural, more efficient and more intuitive by using gaze, speech and gesture Input.
8sense is a platform of virtual coaching systems consisting of sensor technology and a mobile app in the healthcare sector. 8sense helps companies to save healthcare costs and private individuals to reach their better and healthier me. The company is currently developing a system to combat back pain. 8sense primarily acts as a system provider (B2B), but the coaching systems can also be purchased by the end customer (B2C).
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer cells. Through viral replication within cancer cells, Abalos’ arenavirus-based drug candidates are designed to awake precise innate and adaptive immune responses and activate all relevant immune cell types against primary tumors and metastases. Led by experienced biotech entrepreneurs and immunology pioneers, Abalos’ goal is to achieve a quantum leap in immuno-oncology.
The company was founded in 2014 by Dr. Ralf Hilfrich (technical director) and Stefan Raupach (commercial director) with the vision to establish a new cancer screening program for the early detection of HPV-induced mouth and throat cancer. The two founders combine more than 40 years of experience in the development, manufacturing and marketing of in-vitro diagnostics. Located in Ammersbek near Hamburg, the company distributes the rapid test since 2015 to dentists, dermatologists and other specialists, who offer cancer prevention services to their patients.
Adikteev offers a marketing platform with its own Data Management Platform (DMP) solution and an advertising network with over 400 connected publishers. The large number of tools enables the placement of targeted advertising in real time, broken down to the individual user, and enormously increases the conversion rate.
adivo is a biotech company generating therapeutic antibodies for companion animals, addressing the medical needs in dogs, with an upside potential for a future in care for other species.
Antibody selection is based on a novel fully synthetic, dog-specific phage display library that allows de-novo identification of antibodies to select a drug candidate with optimal properties.
adivo is a spin-off from MorphoSys AG, a leading European biopharmaceutical company. The team transfers an in-depth expertise in discovery and development of human therapeutic antibodies to the veterinary market.
Das Start-up ADLATUS Robotics adressiert den neuen, rasant wachsenden Markt der professionellen Servicerobotik mit innovativen Produkten wie dem Reinigungsroboter CR700.
Ob es um die Reinigung von Großmärkten, die Rasenpflege oder Security geht: Service-Roboter wie der Reinigungsroboter CR700 von ADLATUS Robotics übernehmen immer mehr Aufgaben autonom oder in Kooperation mit Menschen. Damit sparen Firmen im Bereich des Facility Managements, aber auch Endkunden aus Industrie und Handel, Kosten. Es kommt hinzu: Oft fehlt qualifiziertes Personal, die Sicherheitsanforderungen sind hoch, das Personal wechselt häufig und die Arbeitsbedingungen sind belastend und gefährlich.
Der Service-Roboter CR700 soll in Frühjahr 2017 am Markt eingeführt werden und reinigt autonom und selbständig auch größere Flächen. Das Gerät ist vielfältig vernetzt und kann ideal im täglichen Betrieb eingesetzt werden. Zielgruppe sind Facility Management Unternehmen, die die Reinigung im Auftrag der Endkunden durchführen, aber auch Kunden aus Industrie und Handel, die ihre Objekte in Eigenverantwortung reinigen.
Das Geschäftsmodell des Unternehmens ist es, die Entwicklung, die Produktion, Vermarktung, Vertrieb und Service dieser professionellen Roboter-Produkte eigenständig und wo immer notwendig und sinnvoll in Zusammenarbeit mit Kooperationspartnern umzusetzen.
Adtriba is an efficient and simple cross-channel digital marketing management platform. As the “single point of marketing truth” Adtriba integrates all cross-channel data and applies machine learning to calculate the exact profitability of all marketing touchpoints. The exact performance of every campaign is displayed in a dashboard which allows for cross-channel optimization of marketing ROI.
AdvanceCOR is a drug-developing biotech company which focuses on personalized medicine in cardiovascular diseases. We concentrate on innovative biological drugs in indications with unmet medical needs.
ADVANOVA was founded in January 2012 by Dr. Frank Hemer, a doctor and computer scientist, and Bastian Bleisinger, a computer scientist. The company’s head office is in Erlangen at the centre of Germany’s “Medical Valley”.
Agora Innovation GmbH is a financial technology company focusing on blockchain, DLT and digital assets, founded in 2017 by Phong Dao, Evgeny Matershev and Robert Malec. The product IVE.ONE, with the goal of providing better digital assets for everyone, is a global investment and issuance platform for legally compliant digital securities on the blockchain. The platform combines various national regulatory requirements with the blockchain to protect companies from money laundering and sanction risks. All market participants in the field of digital securities, such as issuers, investors, stock exchanges and others, can this way strictly comply with local and global regulations and have full control over their assets.
AIM3D GmbH is a spin-off company from the University of Rostock with the aim to drastically reduce the cost of the additive manufacturing of metal parts.
During their work, the founders of AIM3D GmbH often dealt with many different types of additive manufacturing processes for plastics, but also for metals and ceramics. During this time, they realized that the industrial transfer of additive manufacturing techniques often failed due to the high material costs, especially when it came to the manufacturing of metal parts. For this reason, AIM3D GmbH was founded not just with the aim of simply building another 3D printer, but to overcome the limitations of materials and to revolutionize the additive manufacturing market from a cost point of view. In order to make this possible, AIM3D GmbH has designed a printer which offers the customer the opportunity to use multiple types of material on one machine and which is much more cost-efficient than current metal printers.
Our top priority is to design customer- and problem-orientated products. We are therefore always happy to hear from you. If you cannot find your desired material on our website, we will most likely still be able to find a solution together – just reach out to us!
AirGateway GmbH is a B2B airline distribution company connecting airlines with corporate, leisure, offline and online travel agents. AirGateway state-of-the-art technology enables airlines and travel agents to enhance their retailing channels bringing rich content, dynamic pricing and ancillary services as defined by IATA’s new New Distribution Capability standard.
akvolution sells water treatment plants equipped with akvoFloatTM —an energy-efficient flotation-filtration process based on ceramic materials— for desalination and industrial wastewater treatment, such as in the oil and gas industry.
Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).
Alentis has in-licensed platform technologies and monoclonal antibodies which are the result of more than a decade of research from the University of Strasbourg and Inserm, the French National Institutes of Health and the Mount Sinai Hospital, New York.
The portfolio is based on profound knowledge and expertise in liver disease, unique patient-derived model systems and the discovery of a novel, very fundamental mechanism of action underlying these diseases.
Alentis has lead monoclonal antibodies which show consistent compelling efficacy and safety in patient-derived cell and animal models.
Furthermore, Alentis has a proprietary discovery platform enabling fast-track discovery and development of compounds and targets that are relevant in the pathology of late stage liver disease and carcinogenesis.
Algiax Pharmaceuticals is a young, innovative research company in the field of neurological diseases with a special focus on neuropathic pain.
The English-language platform on All3DP.com provides consumers and small business users with guidance and practical information and tips as well as a curated marketplace of 3D printable designs and objects.
ALS Automatic Logistic Solutions GmbH, Munich, exclusive manufacturer of automatic box opening systems to cut or perforate cartons, closed at the beginning of this year a significant round of funding.
Altruja provides social fundraising software that can easily and quickly be integrated into any website. Using this software and Web 2.0, aid organizations and other fundraising institutions like universities, associations, schools, political initiatives etc. can reach new contributors and thereby exponentially increase the amount of funds they raise.
Founded in October 2016, ATC ALUVATION Technology Center Paderborn GmbH is a technology company headquartered in Paderborn, eastern Westphalia. ALUVATION founder Markus Belte has been fundamentally shaping the technology used in the heat treating of aluminium components since the 1990s and is one of the world’s leading specialists in this field. The ALUVATION system takes heat treating in a new direction, away from permanently installed environments and into a new, digitalised, mobile, modular and dynamic age of Industry 4.0.
The core competency of AQ Implants GmbH is the endoprosthetic reconstruction of severe and complex defects and anomalies. With the development of innovative implant systems AQ Implants GmbH provides surgeons with various surgical options to reconstruct a wide variety of defects.
Under the brand name REVISIO they offer a complete range of implants for the treatment of revision and tumour cases, from easy revision cases to modular-complex defect treatments.
Ark-Biodiversity is a green high-tech company. The company makes species protection possible by using their many years of scientific know-how, the latest genomic methods and custom adapted big-data technologies. Ark develops a universal test, the "Universal Fingerprint of Life", with which any living being and its products can be identified and characterized. Therefore they use blockchain-based technology, which provides the information gained in a contract- and counterfeit-proof manner for market participant – all for the protection of species and to prevent illegal animal trade.
"Asana Rebel - Yoga Inspired Fitness" is a successful growing mobile fitness app. We are an international and dedicated team, based in the heart of Berlin. Our app has been featured multiple times by Apple and Google and is rated as one of the top health & fitness apps, with an average of more than 4.6 / 5 stars. With millions of users and a great vision, we strive to achieve global success. For this journey ahead, we are looking to further build up our team of bright minds and impressive personalities.
A great vision needs great people.
Atriva Therapeutics stands for the next generation of antiviral therapies. MEK Inhibitors have high potential as truly efficacious and safe antiviral drugs to address the urgent need e.g. for a novel, broadly active influenza therapy.
Attenio GmbH develops software for manual assembly tasks of complex and varied products. The software package perfectly integrates the production staff into the digital information flow. Order data associated with the assembly order is extracted from the order management systems via direct interfaces and assigned to the correct 3D product data. The software is consistently geared to the needs of the fitters.
AudioCure Pharma specializes in the preclinical and clinical development of small molecules for the treatment of audiological and neurodegenerative diseases like sudden hearing loss, tinnitus, Parkinson’s and Alzheimer’s disease. In a first step the company focuses on sudden hearing loss.
Our compounds AC102 and AC002 have shown excellent efficacy in different animal models for the above-mentioned indications. Consequently, AudioCure is on its way to perform formal preclinical tests and to move AC102 into first-in-man testing.
autoaid is developing a self-learning, web-based car diagnostic system for professional use in car garages and operates the car service platform autoaid.de.
AYOXXA is a biotechnology company that has developed the LUNARISTM platform, a revolutionary technology for the multiplex analysis of proteins. The business model is comparable to that of iTunes. Like iPhones, AYOXXA's biochips can be used in a whole range of analyses. The biomarkers are provided by AYOXXA itself and also by cooperation partners.
At the core of this patented technology are the so-called "In-situ Encoded Bead Arrays" (IEBA), which enable the simultaneous analysis of different proteins in an accurate, cost-effective and very small sample size. These novel biochips are used in pharmacological screening and biomedical research. Since 2018, more than 20 LUNARISTM readers have been placed with international pharmaceutical companies and AYOXXA generates growing revenues from the sale of consumables.